If Novo Nordisk A/S’s wildly popular weight-loss drug succeeds in a highly anticipated trial for Alzheimer’s disease, Biogen Inc.’s Chief Executive Officer Chris Viehbacher doesn’t see it as a ...

Assisted living residents living with dementia face significant communication barriers when transferred to emergency departments, and a specialized care coordination program may help bridge gaps, ...